205 related articles for article (PubMed ID: 16452545)
1. Bone mineral density and bone turnover in young adult survivors of childhood acute lymphoblastic leukaemia.
Jarfelt M; Fors H; Lannering B; Bjarnason R
Eur J Endocrinol; 2006 Feb; 154(2):303-9. PubMed ID: 16452545
[TBL] [Abstract][Full Text] [Related]
2. Bone mineral density and markers of bone turnover in young adult survivors of childhood lymphoblastic leukaemia.
Hoorweg-Nijman JJ; Kardos G; Roos JC; van Dijk HJ; Netelenbos C; Popp-Snijders C; de Ridder CM; Delemarre-van de Waal HA
Clin Endocrinol (Oxf); 1999 Feb; 50(2):237-44. PubMed ID: 10396368
[TBL] [Abstract][Full Text] [Related]
3. Bone mineral density in patients with growth hormone deficiency: does a gender difference exist?
Hitz MF; Jensen JE; Eskildsen PC
Clin Endocrinol (Oxf); 2006 Dec; 65(6):783-91. PubMed ID: 17121531
[TBL] [Abstract][Full Text] [Related]
4. Reduced bone mineral density in young adults following cure of acute lymphoblastic leukaemia in childhood.
Brennan BM; Rahim A; Adams JA; Eden OB; Shalet SM
Br J Cancer; 1999 Apr; 79(11-12):1859-63. PubMed ID: 10206305
[TBL] [Abstract][Full Text] [Related]
5. Bone remodeling and bone mineral density during pregnancy.
Ulrich U; Miller PB; Eyre DR; Chesnut CH; Schlebusch H; Soules MR
Arch Gynecol Obstet; 2003 Oct; 268(4):309-16. PubMed ID: 14504876
[TBL] [Abstract][Full Text] [Related]
6. Determinants of bone density in healthy older men with low testosterone levels.
Kenny AM; Prestwood KM; Marcello KM; Raisz LG
J Gerontol A Biol Sci Med Sci; 2000 Sep; 55(9):M492-7. PubMed ID: 10995046
[TBL] [Abstract][Full Text] [Related]
7. Correlations between biochemical markers of bone turnover and bone density responses in patients with glucocorticoid-induced osteoporosis treated with teriparatide or alendronate.
Burshell AL; Möricke R; Correa-Rotter R; Chen P; Warner MR; Dalsky GP; Taylor KA; Krege JH
Bone; 2010 Apr; 46(4):935-9. PubMed ID: 20060081
[TBL] [Abstract][Full Text] [Related]
8. Correlations of serum prolidase activity between bone turnover markers and mineral density in postmenopausal osteoporosis.
Verit FF; Geyikli I; Yazgan P; Celik A
Arch Gynecol Obstet; 2006 Jun; 274(3):133-7. PubMed ID: 16532321
[TBL] [Abstract][Full Text] [Related]
9. Bone mineral density: serum markers of bone turnover and their relationships in peritoneal dialysis.
Negri AL; Barone R; Quiroga MA; Bravo M; Marino A; Fradinger E; Bogado CE; Zanchetta JR
Perit Dial Int; 2004; 24(2):163-8. PubMed ID: 15119637
[TBL] [Abstract][Full Text] [Related]
10. Improvement in bone mineral density and body composition in survivors of childhood acute lymphoblastic leukemia: a 1-year prospective study.
Marinovic D; Dorgeret S; Lescoeur B; Alberti C; Noel M; Czernichow P; Sebag G; Vilmer E; Léger J
Pediatrics; 2005 Jul; 116(1):e102-8. PubMed ID: 15995009
[TBL] [Abstract][Full Text] [Related]
11. Alterations in bone turnover and impaired development of bone mineral density in newly diagnosed children with cancer: a 1-year prospective study.
Arikoski P; Komulainen J; Riikonen P; Voutilainen R; Knip M; Kröger H
J Clin Endocrinol Metab; 1999 Sep; 84(9):3174-81. PubMed ID: 10487683
[TBL] [Abstract][Full Text] [Related]
12. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis.
Garnero P; Sornay-Rendu E; Chapuy MC; Delmas PD
J Bone Miner Res; 1996 Mar; 11(3):337-49. PubMed ID: 8852944
[TBL] [Abstract][Full Text] [Related]
13. Long-term effects of growth hormone (GH) on bone mineral status and bone turnover markers in patients with isolated GH deficiency and multiple pituitary hormone deficiency.
Gonc EN; Kandemir N
Clin Endocrinol (Oxf); 2007 May; 66(5):672-7. PubMed ID: 17381489
[TBL] [Abstract][Full Text] [Related]
14. Identification of metabolic bone disease in patients with endogenous hyperthyroidism: role of biological markers of bone turnover.
Jódar Gimeno E; Muñoz-Torres M; Escobar-Jiménez F; Quesada Charneco M; Luna del Castillo JD; Oleà N
Calcif Tissue Int; 1997 Nov; 61(5):370-6. PubMed ID: 9351877
[TBL] [Abstract][Full Text] [Related]
15. Serum levels of immunoreactive bone sialoprotein in osteoporosis: positive relations to established biochemical parameters of bone turnover.
Fassbender WJ; Ruf T; Kaiser HE; Stracke H
In Vivo; 2000; 14(5):619-24. PubMed ID: 11125546
[TBL] [Abstract][Full Text] [Related]
16. Secondary osteoporosis in liver transplant recipients: a longitudinal study in patients with and without cholestatic liver disease.
Bjøro K; Brandsaeter B; Wiencke K; Bjøro T; Godang K; Bollerslev J; Schrumpf E
Scand J Gastroenterol; 2003 Mar; 38(3):320-7. PubMed ID: 12737449
[TBL] [Abstract][Full Text] [Related]
17. [Bone mineral density and markers of bone turnover in patients treated for malignant disease in childhood].
Muszyńska-Rosłan K; Konstantynowicz J; Krawczuk-Rybak M; Łuczyński W; Kaczmarski M; Wołczynski S; Piotrowska-Jastrzebska J
Med Wieku Rozwoj; 2004; 8(4 Pt 2):1041-54. PubMed ID: 15951599
[TBL] [Abstract][Full Text] [Related]
18. Bone mineral density and body composition before and during treatment with gonadotropin-releasing hormone agonist in children with central precocious and early puberty.
Boot AM; De Muinck Keizer-Schrama S; Pols HA; Krenning EP; Drop SL
J Clin Endocrinol Metab; 1998 Feb; 83(2):370-3. PubMed ID: 9467543
[TBL] [Abstract][Full Text] [Related]
19. Relationship of bone turnover to bone density and fractures.
Melton LJ; Khosla S; Atkinson EJ; O'Fallon WM; Riggs BL
J Bone Miner Res; 1997 Jul; 12(7):1083-91. PubMed ID: 9200008
[TBL] [Abstract][Full Text] [Related]
20. Bone mineral density and bone turnover before and after surgical cure of Cushing's syndrome.
Hermus AR; Smals AG; Swinkels LM; Huysmans DA; Pieters GF; Sweep CF; Corstens FH; Kloppenborg PW
J Clin Endocrinol Metab; 1995 Oct; 80(10):2859-65. PubMed ID: 7559865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
